These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. Should optical coherence tomography be used to manage patients with multiple sclerosis? Costello F; Van Stavern GP J Neuroophthalmol; 2012 Dec; 32(4):363-71. PubMed ID: 23196948 [No Abstract] [Full Text] [Related]
66. Optical Coherence Tomography in Neuro-ophthalmology. Costello F Neurol Clin; 2017 Feb; 35(1):153-163. PubMed ID: 27886892 [TBL] [Abstract][Full Text] [Related]
67. MRI of acute optic neuritis (ON) at the first episode: Can we predict the visual outcome and the development of multiple sclerosis (MS)? Cellina M; Floridi C; Rosti C; Orsi M; Panzeri M; Pirovano M; Ciocca M; Oliva G; Gibelli D Radiol Med; 2019 Dec; 124(12):1296-1303. PubMed ID: 31435862 [TBL] [Abstract][Full Text] [Related]
68. Author reply: To PMID 24268855. Garcia-Martin E; Polo V; Larrosa JM; Marques ML; Pablo LE Ophthalmology; 2014 Nov; 121(11):e63-4. PubMed ID: 25444946 [No Abstract] [Full Text] [Related]
69. Multiple sclerosis with ophthalmologic onset - case report. Costin D; Pînzaru GM; Pătraşcu AM; Moţoc A; Moraru AD Rom J Ophthalmol; 2018; 62(1):78-82. PubMed ID: 29796438 [TBL] [Abstract][Full Text] [Related]
70. Assessing the anterior visual pathway in optic neuritis: recent experimental and clinical aspects. Dietrich M; Aktas O; Hartung HP; Albrecht P Curr Opin Neurol; 2019 Jun; 32(3):346-357. PubMed ID: 30694926 [TBL] [Abstract][Full Text] [Related]
71. Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Frohman EM; Fujimoto JG; Frohman TC; Calabresi PA; Cutter G; Balcer LJ Nat Clin Pract Neurol; 2008 Dec; 4(12):664-75. PubMed ID: 19043423 [TBL] [Abstract][Full Text] [Related]
72. [Ophthalmological findings in paediatric and adolescent multiple sclerosis]. Pfriem M; Ababneh L; Schittkowski MP Klin Monbl Augenheilkd; 2012 Oct; 229(10):1021-3. PubMed ID: 22826186 [TBL] [Abstract][Full Text] [Related]
75. Optical Coherence Tomography to Assess Neurodegeneration in Multiple Sclerosis. Petzold A Methods Mol Biol; 2016; 1304():131-41. PubMed ID: 25476442 [TBL] [Abstract][Full Text] [Related]
76. Retinal OCT Texture Analysis for Differentiating Healthy Controls from Multiple Sclerosis (MS) with/without Optic Neuritis. Tazarjani HD; Amini Z; Kafieh R; Ashtari F; Sadeghi E Biomed Res Int; 2021; 2021():5579018. PubMed ID: 34337030 [TBL] [Abstract][Full Text] [Related]
77. The optic nerve should be included as one of the typical CNS regions for establishing dissemination in space when diagnosing MS - No. Tintoré M; Montalban X Mult Scler; 2018 Feb; 24(2):123-125. PubMed ID: 29059000 [No Abstract] [Full Text] [Related]
78. Advances in ophthalmic structural and functional measures in multiple sclerosis: do the potential ocular biomarkers meet the unmet needs? Jiang H; Delgado S; Wang J Curr Opin Neurol; 2021 Feb; 34(1):97-107. PubMed ID: 33278142 [TBL] [Abstract][Full Text] [Related]
79. [An analysis of the structural-topographic interaction of the localization of demyelination and optic nerve lesions in patients with multiple sclerosis]. Ioyleva EE; Krivosheeva MS; Smirnova MA Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(10):15-21. PubMed ID: 31793538 [TBL] [Abstract][Full Text] [Related]
80. Diagnostic Performance of Adding the Optic Nerve Region Assessed by Optical Coherence Tomography to the Diagnostic Criteria for Multiple Sclerosis. Bsteh G; Hegen H; Altmann P; Auer M; Berek K; Di Pauli F; Kornek B; Krajnc N; Leutmezer F; Macher S; Rommer PS; Zebenholzer K; Zulehner G; Zrzavy T; Deisenhammer F; Pemp B; Berger T; Neurology; 2023 Aug; 101(8):e784-e793. PubMed ID: 37400245 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]